Twice-yearly injection slows Alzheimer's decline in trial
20 November 2026
A twice-yearly injection has halved the rate of cognitive decline in people with Alzheimer's, a conference in Boston has heard.
Patients given low-dose diranersen in a trial showed 54% less decline on a test of memory and thinking over nearly two years. Scientists called the results "thrilling", and research campaigners say the discovery is part of "a new era" in Alzheimer's treatment.
-
Donate NowWe're a not for profit, please help support our work for Carers with a donation.
-
MyraMyra is your trusted companion for navigating hospital stays, recovery, and ongoing care at home.
-
Listen to our companion stationEasy listening from the likes of Ella Fitzgerald, Matt Monro and Shirley Bassey.